Transmedics Group Inc

Stage 1 is forming an early base after a terminal decline, with a Lockout Rally pattern driving forced upside repricing and confirming institutional demand. Price is holding above rising 9EMA and 21EMA with no exhaustion, creating a bullish asymmetry over the medium term. The Lockout Rally override gives execution permission now, aligning short-term readiness with medium-term bias. Buy now.

• ↑Q1 revenue $174M, +21% YoY; 2026 guidance $727–757M
• ↑Europe expansion with PAD Aviation could double market reach
• ↓Transplant Modernization Act changes create donor volume volatility